July 2023 in “CRC Press eBooks” This review explores plant-based pharmacological advances for treating polycystic ovary syndrome, reporting no new clinical results but highlighting potential benefits for menstrual cycle regulation and testosterone reduction.
42 citations
,
January 2024 in “Frontiers in Endocrinology” This review discusses polycystic ovary syndrome treatments, focusing on the potential benefits and safety of herbs and phytochemicals, and reports no new clinical results.
17 citations
,
December 2015 in “BMC Complementary and Alternative Medicine” This study found that Avicennia marina extract significantly inhibited 5α-reductase type 1 activity in human hair dermal papilla cells, suggesting its potential use for treating androgenic alopecia.
16 citations
,
September 2018 in “Journal of Ethnopharmacology” This review discusses the role of inheritance, androgens, and microinflammation in androgenetic alopecia and suggests some plant-based folk remedies may help address these factors but reports no new clinical results.
This chapter reviews nanocarriers for acne therapy, highlighting their ability to reduce lesions and inflammation while improving the safety and effectiveness of treatment, though no new clinical results are reported.
3 citations
,
December 2018 in “PubMed” This study provides an overview of popular over-the-counter hair loss products, highlighting limited evidence for non-approved treatments and suggesting the need for more rigorous studies.
2 citations
,
July 2020 in “PubMed” This review examined herbal and fungal medicines used for treating androgenic alopecia, detailing 23 medicinal plants and fungi alongside their potential mechanisms and active constituents, aiming to inspire new, more effective formulations with fewer side effects.
August 2026 in “Biology Bulletin Reviews” This study found that extracts from Avicennia marina, Moringa oleifera, and Calotropis procera demonstrated strong antibacterial, antioxidant, and hair-growth-promoting properties, with A. marina showing the most pronounced effects.
June 2025 in “British Journal of Dermatology” This systematic review found that licensed hair gloss products in the UK provide significant cosmetic benefits like improved shine and smoothness, but 18% contain harmful additives, highlighting the need for stricter regulations and patient education on product safety.
April 2024 in “International journal of women's health” This review explores adult female acne, focusing on its multifactorial causes, treatment options, and impact on quality of life, but reports no new clinical results.
This review highlights the potential of plant-derived natural compounds as biocompatible and biodegradable materials in dermal and transdermal delivery systems, emphasizing their unexplored benefits and detailing recent advances in isolation techniques and drug delivery technologies.
August 2026 in “IJPAR JOURNAL” This review discusses Ayurvedic treatments for alopecia, emphasizing their pharmacological mechanisms and novel drug delivery methods, but reports no new clinical results.
August 2026 in “IJPAR JOURNAL” This review examines Ayurvedic treatments for alopecia, highlighting their pharmacological mechanisms and drug delivery innovations, but does not report new clinical findings.
August 2022 in “Aesthetic Cosmetology and Medicine” In this study, researchers analyzed plant materials with high anti-seborrhoeic potential, reviewing current studies on plant extracts that may offer therapeutic effects against seborrhea, suggesting that natural cosmetic formulations could safely reduce seborrhea without causing side effects.
January 2020 in “Elsevier eBooks” This chapter provides an overview of phytochemicals with properties to combat alopecia and discusses the potential of flavonoids, found in several herbs, as a safer alternative to synthetic hair loss treatments due to their long-term skin compatibility.
July 2022 in “Revista Científica de Estética e Cosmetologia” This integrative literature review reported that various topical and professional treatments for androgenetic alopecia generally provided satisfactory results for patients seeking to address hair loss.
14 citations
,
December 2011 in “Archives of Dermatological Research” This study found that phyto-vesicles of ß-sitosterol showed better absorption and improved activity for treating androgenetic alopecia in rats compared to the compound and its complex.
April 2026 in “Dermatological Reviews” In this study, both radiofrequency microneedling and ultrasound treatments with a plant-based secretory factor hair serum enhanced hair and scalp health in subjects with androgenetic alopecia, with ultrasound showing more pronounced improvements in hair appearance, density, and color.
July 2025 in “Journal of Pharmacognosy and Phytochemistry” This review explores the potential benefits of plant-based diets, herbal remedies, and phytochemicals for managing PCOS, suggesting they may help regulate menstrual cycles, improve metabolic parameters, and reduce androgen levels, offering a promising, holistic approach to treatment.
April 2026 in “ACS Applied Materials & Interfaces” In this study, researchers developed a fast-dissolving microneedle patch delivering minoxidil nanoparticles and plant-derived vesicles, which improved hair regrowth and follicle health in a mouse model of androgenetic alopecia by reducing oxidative stress and inflammation without causing skin irritation or systemic toxicity.
11 citations
,
April 2025 in “Pharmaceutics” In this review, researchers explore various treatment options for alopecia, focusing on nano-drug delivery systems using plant-based substances, which are potentially effective and less harmful than current treatments, while also highlighting emerging trends such as 3D bioprinting and plant extracts for future therapies.
December 2024 in “International Journal of Scientific Reports” This study found that OZiva+ advanced hair growth serum significantly increased hair follicle length and showed no irritation, indicating it may be a safer alternative to traditional hair loss treatments like minoxidil.
This study identified seven new compounds from the plant Sansevieria trifasciata Prain and predicted that four of them may have better anti-alopecia activity than minoxidil through an in silico approach.
67 citations
,
February 2015 in “Life Sciences” This review discusses phytotherapy options for managing benign prostatic hyperplasia, noting some herbal agents show promise in trials for mild-moderate symptoms but more evidence is needed for others.
2 citations
,
January 2019 in “Indian Dermatology Online Journal” This paper summarizes the foundation and proceedings of the first International Congress of SAARCUM, which addressed the growing issue of antifungal therapy failures in South Asia but reports no new research findings.
July 2026 in “Clinical Cosmetic and Investigational Dermatology” In this study, a liposomal-encapsulated Sesbania grandiflora formulation significantly improved hair and scalp health in adults with hair loss over 180 days, showing enhanced hair density, thickness, growth rate, and tensile strength compared to placebo, with no related adverse events reported.
July 2026 in “DOAJ (DOAJ: Directory of Open Access Journals)” This study found that the liposomal Sesbania grandiflora formulation significantly improved hair and scalp health in adults with hair loss compared to placebo over 180 days, enhancing factors such as hair density, thickness, growth rate, and tensile strength, with no related adverse events reported.
December 2025 in “JAAD reviews.” This research discussed the historical use of plants as dermatologic remedies and how some botanicals independently gained recognition for their medicinal properties across cultures, contributing to the field of pharmacognosy and modern skincare.
January 2025 in “Faculty of 1000 Research Ltd” Plant-based treatments may help reduce BPH symptoms, but more research is needed.
January 2015 in “Современные проблемы науки и образования” This article reviews the use of phytochemicals in hair masks for addressing hair and scalp issues like damage and seborrhea, without reporting new clinical results.